Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...
MedPage Today on MSN
Psilocybin failed to live up to hype for treatment-resistant depression
Researchers questioned psychedelic's true efficacy in unblinded trials ...
People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little ...
SANTA ANA, CA - March 16, 2026 - PRESSADVANTAGE - Moment of Clarity has published a new educational resource detailing ...
Understanding what depression is – and what it is not – is often the first step toward relief.
People living with depression cannot just get over it. They need support, healing, and to discover the epicenter of their ...
Additionally, some patients report distressing withdrawal symptoms when they try to stop, such as insomnia, anxiety, and ...
Drugs like psilocybin that induce psychedelic effects have shown promise for treating depression. Now, a review of the ...
The study findings may spark treatment innovations for depression and anxiety.
TMS is a well-established therapy for treatment-resistant depression. Large clinical studies show that it significantly reduces symptoms in 60 to 70% of patients, and 25 to 35% achieve remission. Most ...
A landmark paper published in Lancet Psychiatry—the largest-ever review of the safety and efficacy of cannabinoids across a ...
Researchers have discovered a surprising change in how cells produce energy in people with depression. Brain and blood cells in young adults with major depressive disorder produced more energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results